Department of Respiratory Medicine, Catharina Hospital, Eindhoven, The Netherlands; Department of Respiratory Medicine, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
J Bone Miner Res. 2013 Oct;28(10):2186-93. doi: 10.1002/jbmr.1947.
Osteoporosis is frequently seen in patients with chronic obstructive pulmonary disease (COPD). Because research on bone structure and bone strength in COPD patients is limited, the objectives of this pilot study were as follows: (1) to compare bone structure, stiffness, and failure load, measured at the peripheral skeleton, between men with and without COPD after stratification for areal bone mineral density (aBMD); and (2) to relate clinical parameters with bone stiffness and failure load in men with COPD. We included 30 men with COPD (normal aBMD, n = 18; osteoporosis, n = 12) and 17 men without COPD (normal aBMD, n = 9; osteoporosis, n = 8). We assessed pack-years of smoking, body mass index (BMI), fat free mass index (FFMI), pulmonary function (forced expiratory volume in 1 second [FEV1 ], FEV1 /forced vital capacity [FVC], diffusion capacity for carbon monoxide [DLCO], and transfer coefficient for carbon monoxide [KCO]), and extent of emphysema. Bone structure of the distal radius and tibia was assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT), and bone stiffness and failure load of the distal radius and tibia were estimated from micro finite element analysis (µFEA). After stratification for aBMD and COPD, men with osteoporosis showed abnormal bone structure (p < 0.01), lower bone stiffness (p < 0.01), and lower failure load (p < 0.01) compared with men with normal aBMD, and men with COPD had comparable bone structure, stiffness, and failure load compared with men without COPD. In men with COPD, lower FFMI was related with lower bone stiffness, and failure load of the radius and tibia and lower DLCO and KCO were related with lower bone stiffness and failure load of the tibia after normalization with respect to femoral neck aBMD. Thus, this pilot study could not detect differences in bone structure, stiffness, and failure load between men with and without COPD after stratification for aBMD. FFMI and gas transfer capacity of the lung were significantly related with bone stiffness and failure load in men with COPD after normalization with respect to femoral neck aBMD.
骨质疏松症在慢性阻塞性肺疾病(COPD)患者中很常见。由于对 COPD 患者骨结构和骨强度的研究有限,本研究的目的如下:(1)在按骨密度(aBMD)分层后,比较男性 COPD 患者和非 COPD 患者外周骨骼的骨结构、刚度和失效负荷;(2)将临床参数与 COPD 男性的骨刚度和失效负荷相关联。我们纳入了 30 名 COPD 男性(正常 aBMD,n=18;骨质疏松症,n=12)和 17 名非 COPD 男性(正常 aBMD,n=9;骨质疏松症,n=8)。我们评估了吸烟的包年数、体重指数(BMI)、无脂肪质量指数(FFMI)、肺功能(1 秒用力呼气量[FEV1]、FEV1/用力肺活量[FVC]、一氧化碳弥散量[DLCO]和一氧化碳转移系数[KCO])以及肺气肿程度。通过高分辨率外周定量计算机断层扫描(HR-pQCT)评估远端桡骨和胫骨的骨结构,并通过微有限元分析(µFEA)估计远端桡骨和胫骨的骨刚度和失效负荷。在按 aBMD 和 COPD 分层后,与正常 aBMD 的男性相比,骨质疏松症的男性表现出异常的骨结构(p<0.01)、较低的骨刚度(p<0.01)和较低的失效负荷(p<0.01),而 COPD 的男性与非 COPD 的男性具有可比的骨结构、刚度和失效负荷。在 COPD 男性中,较低的 FFMI 与桡骨和胫骨的骨刚度和失效负荷较低相关,较低的 DLCO 和 KCO 与胫骨的骨刚度和失效负荷较低相关,且均与股骨颈 aBMD 归一化后相关。因此,在按 aBMD 分层后,本研究未能检测到男性 COPD 患者和非 COPD 患者之间的骨结构、刚度和失效负荷的差异。FFMI 和肺气体转移能力与 COPD 男性股骨颈 aBMD 归一化后的骨刚度和失效负荷显著相关。